H1-Antihistamines Reduce the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus, Hepatitis C Virus, or Dual Hepatitis B Virus-Hepatitis C Virus Infection

H1-antihistamines (AHs) may exert protective effects against cancer. This study investigated the association of AH use with the risk of hepatocellular carcinoma (HCC) in patients with hepatitis B virus (HBV), hepatitis C virus (HCV), or dual HBV-HCV virus infection. MATERIALS AND METHODS: Patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Yu-Chuan, Hsu, Hui-Ching, Lin, Tzu-Min, Chang, Yu-Sheng, Hu, Li-Fang, Chen, Lung-Fang, Lin, Sheng-Hong, Kuo, Pei-I., Chen, Wei-Sheng, Lin, Yi-Chun, Chen, Jin-Hua, Liang, Yu-Chih, Chang, Chi-Ching
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987217/
https://www.ncbi.nlm.nih.gov/pubmed/35044851
http://dx.doi.org/10.1200/JCO.21.01802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987217/
https://www.ncbi.nlm.nih.gov/pubmed/35044851
http://dx.doi.org/10.1200/JCO.21.01802

Ejemplares similares